CDK6 and cancer: Numerous studies have reported that miR-29s suppressed the proliferation and invasion of cancer cells by inhibiting the expression of CDK6 in different types of malignancies, including osteosarcoma [31], and gastric carcinoma [43,44], and bladder cancer [45].